Wolfgang Miesbach – ASH 2025: What’s Coming in Bleeding and Thrombosis?
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn:
”By The Numbers
– 8,200 abstracts (record-breaking)
– 650-980 hemostasis-focused presentations across 8 categories
– 50 Sanofi abstracts | 46 Roche | 25+ Takeda contributions
– 6 late-breaking abstracts drop December 1 + 6 plenary abstracts
Haemophilia: Game-Changing Therapies
– Next-Gen Bispecific Antibodies
– Gene Therapy Updates
– RNA Silencing
Platelet Disorders: ITP Innovation
Rilzabrutinib (WAYRILZ) – First BTK inhibitor for ITP
– 65% platelet response vs 33% placebo
– 23% durable response vs 0% placebo
– Reduced bleeding + improved quality of life
– Plus: New data on rilzabrutinib in warm autoimmune hemolytic anemia (wAIHA) and sickle cell disease
Thrombosis: A Major Shift
NEW 2025 ASH/ISTH Pediatric VTE Guidelines
DOACs (rivaroxaban, dabigatran) now preferred over standard care (LMWH/warfarin) for kids with VTE. Oral anticoagulation changing the game.
Novel Thrombolytic Therapy
TargED Biopharmaceuticals’ TGD001 – first-in-human data on VWF-targeting thrombolytic for stroke, PE, and thrombotic thrombocytopenic purpura
Von Willebrand Disease
– VONVENDI Phase 3 pediatric data (supported Sept 2025 FDA approval)
– VGA039 – novel Protein S-targeting antibody with Phase 1/2 multidose results”
Stay updated with Hemostasis Today.
-
May 22, 2026, 17:30Veronica Sanchez: Do You Live with Pain after a Stroke?
-
May 22, 2026, 17:25Maxime Dely: A Simple but Powerful Indicator of Platelet Quality
-
May 22, 2026, 17:24Jim Hoffman: A New Approach to Balancing Host Defense and Tissue Protection
-
May 22, 2026, 17:22Lucia Rugeri: Advancing Multidisciplinary Care for Heavy Menstrual Bleeding in Women with Bleeding Disorders
-
May 22, 2026, 17:20Nour Al-Mozain: Optimizing PBSC Collection Through Real-Time CD34+ Monitoring
-
May 22, 2026, 16:30Buse Bor: New Publication on Therapeutic Interventions for Women with Obstetric APS
-
May 22, 2026, 16:29Danny Hsu: The Reversal Dilemma – Rethinking our approach to DOAC-associated ICH
-
May 22, 2026, 16:28Bartosz Hudzik: High Bleeding Risk Does Not Always Mean Bleeding-Risk Predominance
-
May 22, 2026, 16:26Sandeep De: Omicron COVID Infections Linked to Coronary Thrombosis without Detectable Plaque